Cold Spring Harbor Laboratory Scientists Produce High-Quality Maize Transcriptome with PacBio SMRT Sequencing
Friday, June 24, 2016
Led by CSHL scientists
Iso-Seq analysis of SMRT Sequencing data more than doubled the number of isoforms, corrected numerous previously mis-annotated gene models, and identified many novel genes and long non-coding RNAs. Additionally, the team showed that long reads are even more important than expected for transcriptome studies. The average transcript length in this project — almost 3 kb — is much longer than that from the previous maize annotation, highlighting a strong bias limitation in previous approaches.
“Although data from short-read sequencing have accumulated over recent years, they do not provide full-length sequence for each RNA, limiting their utility for defining alternatively spliced forms,” Wang et al. write. “In some cases, short-read sequencing generates low-quality transcripts, leading to incorrect annotations.”
“We congratulate the scientists at
More information is available in this blog post, and in the paper, “Unveiling the complexity of the maize transcriptome by single-molecule long-read sequencing.”
About Pacific Biosciences
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to future uses, quality or performance of, or benefits of using, products or technologies, and other future events. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, changes in circumstances and other factors that are, in some cases, beyond Pacific Biosciences’ control and could cause actual results to differ materially from the information expressed or implied by forward-looking statements made in this press release. Factors that could materially affect actual results can be found in Pacific Biosciences’ most recent filings with the Securities and Exchange Commission, including Pacific Biosciences’ most recent reports on Forms 8-K, 10-K and 10-Q, and include those listed under the caption “Risk Factors.”
Pacific Biosciences undertakes no obligation to revise or update information in this press release to reflect events or circumstances in the future, even if new information becomes available.
Nicole Litchfield415.793.6468 firstname.lastname@example.org Investors: Trevin Rard650.521.8450 email@example.com
News Provided by Acquire Media